You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
澳門錄1宗輸入性新冠確診病例 另1名由美回澳居民列輸入性新冠無症狀感染者
澳門新型冠狀病毒感染應變協調中心昨(27日)表示,澳門新增1例輸入性確診病例,為12月26日公布的1例輸入性新冠病毒無症狀感染者,12月27日出現相關症狀轉為確診,為澳門第78例確診病例;經病毒基因序列測試,證實患者所感染的病毒為Omicron變異株。 該病例為23歲男性澳門居民,12月23日由美國出發,經新加坡12月25日抵澳,入境時隨即接受鼻咽拭子檢測,結果對新型冠狀病毒檢測呈陽性,列為無症狀感染者。結果顯示,患者所感染的病毒為近期才在世界各地發現的Omicron變異株,該個案為本澳首個Omicron變異株感染個案。 此外,澳門新型冠狀病毒感染應變協調中心今早公布,1名於昨(27日)日由美國經新加坡回澳的澳門居民新冠病毒核酸檢測呈陽性,判定為輸入性新冠病毒無症狀感染者。 該人士為62歲男性,今年2月、3月和11月共接種3劑Moderna生產的mRNA疫苗,12月24日在美國接受新冠病毒核酸檢測結果為陰性,25日乘坐航班SQ037由美國洛杉磯前往新加坡(座位62E),27日再由新加坡乘坐航班TR904回澳(座位20A);入境時隨即接受鼻咽拭子檢測,結果對新型冠狀病毒檢測呈陽性。應變協調中心表示,目前該人士無新冠肺炎疑似症狀,結合其流行病學史、臨床表現及檢測結果,判定為輸入性新冠病毒無症狀感染者,不列入本澳新冠病毒肺炎確診病例統計。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account